Corbus Pharmaceuticals
CRBP
#10362
Rank
โ‚ฌ38.69 M
Marketcap
1,88ย โ‚ฌ
Share price
-15.40%
Change (1 day)
-81.99%
Change (1 year)

Earnings for Corbus Pharmaceuticals (CRBP)

Earnings in 2026 (TTM): -โ‚ฌ90.1 Million

According to Corbus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ75.51 Million a decrease over its 2024 earnings that were of -โ‚ฌ34.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corbus Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ90.1 Million19.33%
2025 -โ‚ฌ75.51 Million116.04%
2024 -โ‚ฌ34.95 Million-14.54%
2023 -โ‚ฌ40.9 Million28.56%
2022 -โ‚ฌ31.81 Million-37.68%
2021 -โ‚ฌ51.04 Million-54.41%
2020 -โ‚ฌ0.12 Billion59.28%
2019 -โ‚ฌ70.29 Million35.87%
2018 -โ‚ฌ51.74 Million74.27%
2017 -โ‚ฌ29.69 Million62.94%
2016 -โ‚ฌ18.22 Million125.82%
2015 -โ‚ฌ8.07 Million251.68%
2014 -โ‚ฌ2.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Viking Therapeutics
VKTX
-โ‚ฌ0.58 Billion 500.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-โ‚ฌ0.17 Billion 70.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
-โ‚ฌ0.17 Billion 75.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚ฌ31.02 Million-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA